name sense antisense gtctccatcagtggctctacgcccggttcttgttgtattttgvegfr1...

5
Name sense antisense GTCTCCATCAGTGGCTCTACG CCCGGTTCTTGTTGTATTTTG VEGFR1 CTGCCTACCTCACCTGTTTCC CGGCTCTTTCGCTTACTGTTC VEGFR2 GGAAGGCTCTGAAGATAAAGG ACAGAAGATGAGCAGGAGGAG VEGFR3 CTCTGAAGAAGTGGGGTCTGG AAGTAGATGGTGGGCAGGAAG CXCR4 GAPDH ACATCAAGAAGGTGGTGAAGC AAGGTGGAAGAGTGGGAGTTG Supplemental Table 1: PSGL-1 GAGAAGATTGCCACCACTGAC GTTGGACGGTCTCTACTGAGG h-PSGL-1 CAATTTGTCCGTCAACTACCC TGCACACGAAGAAGATAGTGG h-GAPDH GAAGGTGAAGGACGGACTC GAAGATGGTGATGGGATTTC Real - time PCR primers used in the present study h-P-selectin GAAGGTGAAGGACGGACTC GAAGATGGTGATGGGATTTC GGCTGCTGGCTTCTAAGTGTG TTCCGTGACCGGTAAGTATTG TP E-selectin TGACTTGCAAACCACAGGAAC TTACAGCCAAAGCAGCAGGAG <CVR-2014-1358>

Upload: amos-greene

Post on 19-Jan-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Name sense antisense GTCTCCATCAGTGGCTCTACGCCCGGTTCTTGTTGTATTTTGVEGFR1 CTGCCTACCTCACCTGTTTCCCGGCTCTTTCGCTTACTGTTCVEGFR2 GGAAGGCTCTGAAGATAAAGGACAGAAGATGAGCAGGAGGAGVEGFR3

Name sense antisense

GTCTCCATCAGTGGCTCTACG CCCGGTTCTTGTTGTATTTTGVEGFR1

CTGCCTACCTCACCTGTTTCC CGGCTCTTTCGCTTACTGTTCVEGFR2

GGAAGGCTCTGAAGATAAAGG ACAGAAGATGAGCAGGAGGAGVEGFR3

CTCTGAAGAAGTGGGGTCTGG AAGTAGATGGTGGGCAGGAAGCXCR4

GAPDH ACATCAAGAAGGTGGTGAAGC AAGGTGGAAGAGTGGGAGTTG

Supplemental Table 1:

PSGL-1 GAGAAGATTGCCACCACTGAC GTTGGACGGTCTCTACTGAGG

h-PSGL-1 CAATTTGTCCGTCAACTACCC TGCACACGAAGAAGATAGTGG

h-GAPDH GAAGGTGAAGGACGGACTC GAAGATGGTGATGGGATTTC

Real - time PCR primers used in the present study

h-P-selectin GAAGGTGAAGGACGGACTC GAAGATGGTGATGGGATTTC

GGCTGCTGGCTTCTAAGTGTG TTCCGTGACCGGTAAGTATTGTP

E-selectin TGACTTGCAAACCACAGGAAC TTACAGCCAAAGCAGCAGGAG

<CVR-2014-1358>

Page 2: Name sense antisense GTCTCCATCAGTGGCTCTACGCCCGGTTCTTGTTGTATTTTGVEGFR1 CTGCCTACCTCACCTGTTTCCCGGCTCTTTCGCTTACTGTTCVEGFR2 GGAAGGCTCTGAAGATAAAGGACAGAAGATGAGCAGGAGGAGVEGFR3

WT50

100

150 *,**P<0.05

***

Ble

edi

ng t

ime

N=6

0.5

1.0

1.5

2.0

Pla

tele

t co

unts

0

2.5

5

7.5

10

Meg

ak

aryo

cyte

s /

field

WT

A.N=6

IP-/-WT TP-/-

B.

WTC.

D. N=6

IP-/-TP-/-

IP-/-TP-/-

IP-/-TP-/-

Supplemental Figure I

<CVR-2014-1358>

Page 3: Name sense antisense GTCTCCATCAGTGGCTCTACGCCCGGTTCTTGTTGTATTTTGVEGFR1 CTGCCTACCTCACCTGTTTCCCGGCTCTTTCGCTTACTGTTCVEGFR2 GGAAGGCTCTGAAGATAAAGGACAGAAGATGAGCAGGAGGAGVEGFR3

0

0.2

0.4

0.6

0.8

1

1.2

0

20

40

60V

EG

F(p

g/m

l)

IgG P-selectin antibody

IgG P-selectin antibody

WT TP-/-

NS NS

IgG P-selectin antibody

IgG P-selectin antibody

WT TP-/-

NS NS

SD

F-1

(ng

/ml)

Not ligated

A.

B.

Supplemental Figure II

<CVR-2014-1358>

Page 4: Name sense antisense GTCTCCATCAGTGGCTCTACGCCCGGTTCTTGTTGTATTTTGVEGFR1 CTGCCTACCTCACCTGTTTCCCGGCTCTTTCGCTTACTGTTCVEGFR2 GGAAGGCTCTGAAGATAAAGGACAGAAGATGAGCAGGAGGAGVEGFR3

0 24 48 72

P

lasm

a le

vel o

f p

ro M

MP

-9(n

g/m

l)

TP-/-WT

* *

0

30

60

Time (hours)

A.

100

150

200

250

300

TP-/-

WT

0 24 48 72

Pla

sma

leve

l of

SC

F (

pg/m

l)

* **

Time (hours)

B.

Supplemental Figure III

<CVR-2014-1358>

Page 5: Name sense antisense GTCTCCATCAGTGGCTCTACGCCCGGTTCTTGTTGTATTTTGVEGFR1 CTGCCTACCTCACCTGTTTCCCGGCTCTTTCGCTTACTGTTCVEGFR2 GGAAGGCTCTGAAGATAAAGGACAGAAGATGAGCAGGAGGAGVEGFR3

radiation

0

50

100

150

200

250

0

2000

4000

6000

8000

10000

0

50

100

150radiation

0

5000

10000

15000

WT

*

0 7 14 21 28

WT

*

*

0 7 14 21 28(days) (days)

Num

ber

of

Pla

tele

ts (

104/

l)

Num

ber

of

WB

C (

104/

l)

WT

*

Pla

sma

leve

l of

SC

F (

pg

/ml

)

WT

BM

le

vel o

f p

ro-M

MP

9 (

ng

/ml

)

*

TP-/- TP-/-

TP-/- TP-/-

A. B.

C. D.

Supplemental Figure IV

<CVR-2014-1358>